Investigation of product complaints about a prescription drug: implications for pharmacy practice and development pharmaceutics.
Schumann
S C
SC
steven.c.schumann@monsanto.com
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000737:chemistry; D004345:Drug Industry; D000077431:Oxaprozin; D004364:Pharmaceutical Preparations / Q000592:standards*; D010595:Pharmacists; D011422:Propionates / Q000737:chemistry; D013607:Tablets
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004364:Pharmaceutical Preparations; D011422:Propionates; D013607:Tablets; D000077431:Oxaprozin